Hensley Robert Edward sold $1.7M of GL

Hensley Robert Edward (EVP & Chief Investment Officer) sold 10,000 shares of GLOBE LIFE INC. (GL) at an average of $170.07 ($169.53–$170.34, $1.70M total) across 2 trades on 2026-09-22.

Original reporting
SEC EDGAR · Hensley Robert Edward
Published Sep 23, 2026, 4:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 4:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GL
Bearish
medium confidence
Mentioned
$GL
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GLBearishLow
01

Why it matters

The disclosed sale reduces insider ownership, which may be interpreted as a negative signal, but the size is modest.

02

Market read

Primary disclosure of an insider sale; modest relevance for short-term traders.

03

What to watch

Potential upcoming earnings or corporate actions not disclosed could contextualize the sale.

Relevance 6/10Novelty 4/10Timing: post-market 2026-09-22

Background

Globe Life Inc. (GL) is a U.S.-listed insurer. Insider transactions are publicly reported via Form 4.

Company-level read

Ticker impact

$GLBearishMedium confidence
Context

EVP & CIO sold 10,000 shares for $1.7M, reducing his stake to 12,384 shares.

Expected impact

Possible modest dip in GL price over the next few days.

Evidence & confidence

A $1.7M sale by a senior executive is material enough to attract attention, but the amount is modest relative to market cap.

Market effects

Minimal impact on insurance sector; typical insider sales are routine.

No significant regional effect.

Limited to investors tracking Globe Life.

Counterpoint

The sale could be unrelated to confidence, perhaps for personal liquidity, so price may remain stable.

Key entities

  • Globe Life Inc.

    U.S.-listed insurance company (ticker GL).

  • Hensley Robert Edward

    EVP & Chief Investment Officer of Globe Life.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BEMedAI 8/10

Why Stocks Like Bloom Energy and Globe Life Slumped

Bloom Energy (BE) fell 8% despite a 138.9% revenue increase and EPS beat, due to concerns over future revenue and capital expenditure. Globe Life (GL) dropped 8% after reporting 5.3% revenue growth and warning of FY 2026 headwinds. Comfort Systems (FIX) declined 9.26% despite strong earnings and revenue growth, citing higher material costs.

$GLMed

Globe Life Inc (GL) Q3 2026 Earnings Call Highlights: Premium Growth and Buybacks Offset

Globe Life Inc (GL) reported Q3 2026 earnings with total premium revenue up 7%, health premium revenue up 16%, and book value per share rising 23%. The company returned $210M to shareholders and expects to return near 70% of full-year net operating income. However, net income decreased 2%, life underwriting margin fell 5%, and full-year 2026 net operating EPS guidance was reduced to $15.35-$15.65. Management discussed various challenges and strategic plans during the earnings call.

$GLMed

Piper Sandler cuts Globe Life stock rating on medical claims concerns

Piper Sandler downgraded Globe Life (NYSE:GL) to Neutral, lowering its price target to $165 from $200 due to concerns over medical claims volatility. The stock trades at $168.41 with a P/E ratio of 10.97. Q3 results showed revenue of $1.6B, beating estimates, but EPS missed at $4.84. The firm cited exposure to medical claims severity and irregularity in Medicare supplement claims as key issues.